| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Seizures | D012640 | 87 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Glioma | D005910 | 112 associated lipids |
(r)-3-hydroxybutanoic acid
(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid
PubChem Associated disorders and diseases
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with (r)-3-hydroxybutanoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lomas AJ et al. | Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate)/collagen hybrid scaffolds for tissue engineering applications. | 2013 | Tissue Eng Part C Methods | pmid:23281705 |
| Sato T et al. | Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia. | 1998 | Tohoku J. Exp. Med. | pmid:9710942 |
| Ally AI et al. | Trimethyltin as a selective adrenal chemosympatholytic agent in vivo: effect precedes both clinical and histopathological evidence of toxicity. | 1986 | Toxicology | pmid:3726895 |
| Cahill GF and Veech RL | Ketoacids? Good medicine? | 2003 | Trans. Am. Clin. Climatol. Assoc. | pmid:12813917 |
| Sasi P et al. | Characterisation of metabolic acidosis in Kenyan children admitted to hospital for acute non-surgical conditions. | 2006 | Trans. R. Soc. Trop. Med. Hyg. | pmid:16257025 |
| Whisson ME et al. | Quantitative study of starving platelets in a minimal medium: maintenance by acetate or plasma but not by glucose. | 1993 | Transfus Med | pmid:8374698 |
| Laird MD et al. | Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels. | 2013 | Transl Stroke Res | pmid:24323418 |
| Yamaguchi M et al. | Evaluation of temporary portal vein arterialization: the minimum arterialized blood flow for maintaining liver viability. | 1990 | Transpl. Int. | pmid:2271087 |
| Igea J et al. | Evaluation of beta-oxidation parameters and mitochondrial redox state as early markers of hepatic function in hepatic transplantation. | 1999 | Transplant. Proc. | pmid:10500662 |
| Kitabayashi K et al. | Arterial ketone body ratio in clinical liver transplantation. | 1998 | Transplant. Proc. | pmid:9865382 |